stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Lineage Cell Therapeutics IncLCTX
$0.795113.07%-0.1195

Lineage Cell Therapeutics Inc (LCTX)

Lineage Cell Therapeutics Inc Stock (LCTX) Forecast

The Lineage Cell Therapeutics Inc (LCTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5783, representing a -27.27% decrease from the current price of $0.7951. The highest analyst price target is $0.835, and the lowest is $0.3216.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month LCTX Price Target
Average 0.6218 (-21.79% Downside)

Is Lineage Cell Therapeutics Inc (LCTX) A Buy Now?

Oscillators
NameValueAction
RSI(14)33.69Neutral
STOCH(9,6)45.49Neutral
STOCHRSI(14)100.00Sell
MACD(12,26)-0.01Sell
ADX(14)12.67Neutral
William %R-93.03Buy
CCI(14)-255.72Sell
Buy: 1 · Sell: 3 · Neutral: 3Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
1.00
Sell
0.97
Sell
MA20
1.00
Sell
0.99
Sell
MA50
0.99
Sell
1.01
Sell
MA100
1.07
Sell
1.08
Sell
MA200
1.29
Sell
1.20
Sell
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, LCTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 13 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on LCTX, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 33.69 indicates that LCTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 45.49 indicates that LCTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that LCTX is overbought. This suggests that LCTX price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of 12.67 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of -255.72 indicates that LCTX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term LCTX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Lineage Cell Therapeutics Inc financial reports and earnings history, Lineage Cell Therapeutics Inc (LCTX) stock could reach $0.375 by 2030, $2.28 by 2040 and $5.74 by 2050. See the projected annual prices until 2050 of the Lineage Cell Therapeutics Inc stock below:

  • Lineage Cell Therapeutics Inc (LCTX) is expected to reach an average price of $1.31 in 2035, with a high prediction of $1.08 and a low estimate of $0.7335. This indicates an +64.21% change from the last recorded price of $0.7951.
  • Lineage Cell Therapeutics Inc (LCTX) stock is projected to chart a bullish course in 2040, with an average price target of $1.91, representing an +140.28% change from its current level. The forecast ranges from a conservative $1.76 to a sky-high $2.28.
  • Our analysts predict Lineage Cell Therapeutics Inc (LCTX) to change +301.88% by 2045, soaring from $3.23 to an average price of $3.20, potentially reaching $3.85. While $3.23 is the low estimate, the potential upside is significant.
  • Lineage Cell Therapeutics Inc (LCTX) stock is expected to climb by 2050, reaching an average of $4.85, a +510.13% change from its current level. However, a wide range of estimates exists, with high and low targets of $5.74 and $4.89, respectively, highlighting the market's uncertainty.

Lineage Cell Therapeutics Inc Stock (LCTX) Year by Year Forecast

Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2026

The predicted value for Lineage Cell Therapeutics Inc (LCTX) in 2026 is set at an average of $1.20. Estimates vary from a peak of $1.99 to a trough of $0.3216, indicating an +51.09% surge from the present price of $0.7951.

MonthAverageLowHighChange from today's price
December, 2026$0.6416$0.3216$0.835-19.31%

Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Lineage Cell Therapeutics Inc (LCTX) is $0.1448, with a high forecast of $1.24 and a low forecast of $0.00545. This indicates an -81.79% decrease from the last price of $0.7951.

MonthAverageLowHighChange from today's price
January, 2027$0.4248$0.3548$1.24-46.58%
February, 2027$0.00796$0.047$0.4181-99.00%
March, 2027$0.1756$0.00545$0.1246-77.92%
April, 2027$0.1176$0.0176$0.2376-85.21%
May, 2027$0.1859$0.0558$0.1992-76.62%
June, 2027$0.0827$0.2027$0.111-89.60%
July, 2027$0.0195$0.0628$0.1672-97.55%
August, 2027$0.257$0.0829$0.3936-67.68%
September, 2027$0.2202$0.1202$0.4369-72.31%
October, 2027$0.0533$0.0283$0.2585-93.29%
November, 2027$0.1202$0.0534$0.1335-84.89%
December, 2027$0.073$0.047$0.2036-90.82%

Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2028

In 2028, Lineage Cell Therapeutics Inc (LCTX) is projected to reach an average price of $0.1938, with a high projection of $0.384 and a low estimate of $0.011. This indicates an -75.63% fall from the last price of $0.7951.

MonthAverageLowHighChange from today's price
January, 2028$0.1595$0.0137$0.2162-79.94%
February, 2028$0.1873$0.0606$0.2161-76.44%
March, 2028$0.2259$0.0326$0.3159-71.59%
April, 2028$0.0991$0.0791$0.2592-87.54%
May, 2028$0.1955$0.011$0.2455-75.41%
June, 2028$0.1487$0.0988$0.3287-81.29%
July, 2028$0.1752$0.0786$0.3052-77.96%
August, 2028$0.1284$0.0451$0.1985-83.85%
September, 2028$0.2316$0.0721$0.384-70.87%
October, 2028$0.3681$0.1349$0.3681-53.71%
November, 2028$0.2013$0.1713$0.3814-74.69%
December, 2028$0.2045$0.1545$0.2746-74.29%

Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2029

The 2029 price forecast for Lineage Cell Therapeutics Inc Stock (LCTX) is $0.1012 on average, with a high prediction of $0.58 and a low estimate of $0.00576. This represents an -87.28% decrease from the previous price of $0.7951.

MonthAverageLowHighChange from today's price
January, 2029$0.0809$0.016$0.2476-89.82%
February, 2029$0.0659$0.00576$0.0908-91.72%
March, 2029$0.0992$0.1327$0.086-87.53%
April, 2029$0.1238$0.0062$0.1938-84.43%
May, 2029$0.1329$0.0271$0.2371-83.28%
June, 2029$0.0198$0.0248$0.1269-97.51%
July, 2029$0.2367$0.00677$0.4134-70.24%
August, 2029$0.1298$0.0998$0.58-83.67%
September, 2029$0.163$0.0297$0.3929-79.50%
October, 2029$0.0711$0.0164$0.1663-91.06%
November, 2029$0.0327$0.0839$0.0559-95.89%
December, 2029$0.0581$0.0139$0.1793-92.69%

Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2030

Lineage Cell Therapeutics Inc Stock (LCTX) is expected to reach an average price of $0.225 in 2030, with a high forecast of $0.375 and a low forecast of $0.000871. This signifies an -71.71% decrease from the last price of $0.7951.

MonthAverageLowHighChange from today's price
January, 2030$0.1116$0.1032$0.0475-85.96%
February, 2030$0.0291$0.0508$0.0323-96.34%
March, 2030$0.0803$0.0607$0.0189-89.91%
April, 2030$0.4009$0.088$0.0619-49.58%
May, 2030$0.3336$0.3782$0.3234-58.05%
June, 2030$0.2984$0.3724$0.375-62.47%
July, 2030$0.167$0.2369$0.2758-79.00%
August, 2030$0.3287$0.1835$0.271-58.66%
September, 2030$0.3624$0.3694$0.3635-54.42%
October, 2030$0.3283$0.349$0.3615-58.70%
November, 2030$0.1412$0.1659$0.3258-82.25%
December, 2030$0.118$0.000871$0.3573-85.16%

Similar to LCTX